| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/HYPERTENSIONAHA.106.085704 |
| P698 | PubMed publication ID | 17372034 |
| P2093 | author name string | Darcy Richardson | |
| Karl A Nath | |||
| Leslie A Smith | |||
| Zvonimir S Katusic | |||
| Livius V d'Uscio | |||
| Anantha V Santhanam | |||
| P433 | issue | 5 | |
| P304 | page(s) | 1142-1148 | |
| P577 | publication date | 2007-03-19 | |
| P1433 | published in | Hypertension | Q5958695 |
| P1476 | title | Essential role of endothelial nitric oxide synthase in vascular effects of erythropoietin | |
| P478 | volume | 49 |
| Q36698727 | A new model of an arteriovenous fistula in chronic kidney disease in the mouse: beneficial effects of upregulated heme oxygenase-1 |
| Q34885372 | A protective role of ciglitazone in ox-LDL-induced rat microvascular endothelial cells via modulating PPARγ-dependent AMPK/eNOS pathway |
| Q36943965 | Activation of endothelial nitric oxide synthase is critical for erythropoietin-induced mobilization of progenitor cells |
| Q46004329 | Carbamylated erythropoietin-FC fusion protein and recombinant human erythropoietin during porcine kidney ischemia/reperfusion injury. |
| Q37533151 | Cardiovascular effects of erythropoietin an update |
| Q35530060 | Clinical use of erythropoietin in chronic kidney disease: outcomes and future prospects. |
| Q35601395 | Differential effects of eNOS uncoupling on conduit and small arteries in GTP-cyclohydrolase I-deficient hph-1 mice |
| Q84965433 | Dose-dependent ultrastructural and morphometric alterations after erythropoietin treatment in rat femoral artery vasospasm model |
| Q81153672 | Effect of erythropoietin on blood pressure and on the vascular endothelial ET-1/ETB receptor system |
| Q36128396 | Effect of hemoglobin target on progression of kidney disease: a secondary analysis of the CHOIR (Correction of Hemoglobin and Outcomes in Renal Insufficiency) trial |
| Q36824720 | Effects of recombinant human erythropoietin on resistance artery endothelial function in stage 4 chronic kidney disease |
| Q37135746 | Endothelial cells in allograft rejection |
| Q64260709 | Endotoxin-induced cerebral pathophysiology: differences between fetus and newborn |
| Q37781871 | Erythropoietin 2nd cerebral protection after acute injuries: A double-edged sword? |
| Q37376670 | Erythropoietin and a nonerythropoietic peptide analog promote aortic endothelial cell repair under hypoxic conditions: role of nitric oxide |
| Q38637551 | Erythropoietin for the treatment of subarachnoid hemorrhage: A feasible ingredient for a successful medical recipe |
| Q42850017 | Erythropoietin has a restorative effect on the contractility of arteries following experimental hypoxia |
| Q42154729 | Erythropoietin in the critically ill: do we ask the right questions? |
| Q34466094 | Erythropoietin increases bioavailability of tetrahydrobiopterin and protects cerebral microvasculature against oxidative stress induced by eNOS uncoupling |
| Q37107596 | Erythropoietin increases endothelial biosynthesis of tetrahydrobiopterin by activation of protein kinase B alpha/Akt1. |
| Q33857619 | Erythropoietin increases expression and function of vascular copper- and zinc-containing superoxide dismutase |
| Q34668310 | Erythropoietin prevents endothelial dysfunction in GTP-cyclohydrolase I-deficient hph1 mice |
| Q42916923 | Erythropoietin prevents vascular inflammation and oxidative stress in subtotal nephrectomized rat aorta beyond haematopoiesis |
| Q36974229 | Erythropoietin, progenitors, and repair |
| Q39660329 | Erythropoietin-induced neuroprotection requires cystine glutamate exchanger activity |
| Q42922791 | Erythropoietin: a multimodal neuroprotective agent |
| Q37476598 | Functioning of an arteriovenous fistula requires heme oxygenase-2. |
| Q37430884 | JAK redux: a second look at the regulation and role of JAKs in the heart |
| Q37696218 | Nitric oxide and hypoxia stimulate erythropoietin receptor via MAPK kinase in endothelial cells |
| Q37887771 | Nitric oxide: a guardian for vascular grafts? |
| Q39148627 | Progenitor Cells for Arterial Repair: Incremental Advancements towards Therapeutic Reality. |
| Q34979773 | Protecting against vascular disease in brain |
| Q42592368 | Role of alpha-lipoic acid in the management of anemia in patients with chronic renal failure undergoing hemodialysis |
| Q34660330 | Salicylate treatment improves age-associated vascular endothelial dysfunction: potential role of nuclear factor kappaB and forkhead Box O phosphorylation |
| Q34726907 | The SIRT1 activator SRT1720 reverses vascular endothelial dysfunction, excessive superoxide production, and inflammation with aging in mice |
| Q46024749 | Voluntary wheel running restores endothelial function in conduit arteries of old mice: direct evidence for reduced oxidative stress, increased superoxide dismutase activity and down-regulation of NADPH oxidase. |
Search more.